Biocon Launches Yesafili in US, Stock Touches Day High of Rs 429
Biocon surges to Rs 429 on Monday after the company launched its Eylea biosimilar Yesafili in the United States ophthalmology market. Yesafili is Biocon’s biosimilar...
Tag : Biocon
Biocon Gets Health Canada Nod for Psoriasis Autoinjector
Biocon touched a day high of ₹435.50 on Wednesday after its Canadian arm received Health Canada approval for the Yesintek autoinjector pen. Health Canada cleared...
Biocon Shares Hit 52-Week High, Up 3% on EMA Nod
Biocon shares hit a 52-week high of Rs 447.15 on Thursday, up 3%, after its Malaysia unit won EMA approval for a new insulin production...
Biocon Shares Open Green as it Strengthens Malaysia Presence
Shares of Biocon Ltd opened in the green and almost 1% higher on 24 June after the company announced that it has received a significant...
Biocon Shares Gain on Securing Marketing Approval in EU
Shares of Biocon Ltd were trading in the green and 1% higher on 3 July after the company announced securing marketing approval in Europe for...
Nifty Pharma Bleeds Red Over Looming Tariffs Comment
Shares of Indian pharmaceutical businesses, including Gland Pharma Ltd, Laurus Labs Ltd, Glenmark Pharmaceuticals Ltd, and Biocon Ltd, dropped as much as 8% on Monday,...
Biocon Shares Surge 2% on Approval from USFDA for Blood Pressure Drug
Shares of Biocon Ltd were trading in the green and 2% higher on 24 March after the company’s subsidiary announced securing approval from the USFDA...
Biocon Shares Gain 2% as Subsidiary Launches Yesintek in US
Shares of Biocon, a pharmaceutical company, rose by as much as 2% on Tuesday, 25 February, after Biocon Biologics, a fully integrated global biosimilars company...
Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA
Shares of Biocon were trading 4% higher on 13 January after the company’s subsidiary Biocon Biologics’ insulin factory in Malaysia got cleared by the US...
Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag
Shares of Biocon Ltd slumped 4% on Monday, 9 December, after the company’s Bengaluru Unit received an Establishment Inspection Report (EIR) with a Voluntary Action...